MR Lymphangiography: Imaging Strategies to Optimize the Imaging of Lymph Nodes with Ferumoxtran-10
Authors:
- Mukesh G. HarisinghaniMHMukesh G. Harisinghani
- W. Thomas DixonWDW. Thomas Dixon
- Mansi A. SaksenaMSMansi A. Saksena
- Elena BrachtelEBElena Brachtel
- Daniel J. BlezekDBDaniel J. Blezek
- Paritosh J. DhawalePDParitosh J. Dhawale
- Maha TorabiMTMaha Torabi
- Peter F. HahnPHPeter F. Hahn
- 1 May 2004
- journal article
- review article
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 24 (3) , 867-878
Abstract
Detection of local or regional metastases to lymph nodes is clinically important in virtually any type of primary tumor. Current imaging techniques rely heavily on the size criterion for characterization of nodal disease. However, size can be an ineffective parameter for diagnosis of tumor spread to lymph nodes. Magnetic resonance (MR) imaging performed before and after administration of ferumoxtran-10 is a promising technique for characterization of lymph nodes in patients with various primary tumors. Normal homogeneous uptake of ferumoxtran-10 in nonmetastatic nodes shortens the T2 and T2*, turning these nodes dark, whereas malignant nodes lack uptake and remain hyperintense. To optimize acquisition strategies, the following factors should be considered: the timing of contrast material-enhanced imaging, the section thickness, the imaging plane, and the imaging parameters for T2*-weighted sequences. In addition, MR imaging with ferumoxtran-10 allows presurgical mapping of lymph nodes and quantitative estimation of T2*.Keywords
This publication has 28 references indexed in Scilit:
- Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate CancerNew England Journal of Medicine, 2003
- Axillary lymph node metastases: A statistical analysis of various parameters in MRI with USPIOJournal of Magnetic Resonance Imaging, 2002
- MR Imaging of Carcinoma of the VulvaAmerican Journal of Roentgenology, 2002
- MR imaging of mediastinal lymph nodes: Evaluation using a superparamagnetic contrast agentJournal of Magnetic Resonance Imaging, 2000
- Distribution of iron oxide nanoparticles in rat lymph nodes studied using electron energy loss spectroscopy (EELS) and electron spectroscopic imaging (ESI)Journal of Magnetic Resonance Imaging, 2000
- Multicenter clinical trial of ultrasmall superparamagnetic iron oxide in the evaluation of mediastinal lymph nodes in patients with primary lung carcinomaJournal of Magnetic Resonance Imaging, 1999
- Use of USPIO-induced magnetic susceptibility artifacts to identity sentinel lymph nodes and lymphatic drainage patterns. I. dependence of artifact size with subcutaneous Combidex® dose in ratsMagnetic Resonance Imaging, 1998
- Investigation of Mechanisms Influencing the Accumulation of Ultrasmall Superparamagnetic Iron Oxide Particles in Lymph NodesInvestigative Radiology, 1995
- Biodistribution of an ultrasmall superparamagnetic iron oxide colloid, BMS 180549, by different routes of administrationMagnetic Resonance Imaging, 1994
- The role of magnetic resonance imaging and computed tomography in the treatment evaluation of retroperitoneal lymph-node metastases of non-seminomatous testicular tumorsEuropean Journal of Radiology, 1991